CD3e + CD20 (Mosunetuzumab biosimilar) Antibody from ICHORBIO
Search, find, compare suppliers for anti-CD3e + CD20 (Mosunetuzumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | CD3e + CD20 (Mosunetuzumab biosimilar) |
| Clone | monoclonal |
| Host Species | n/a |
| Reactive Species | human |
| Isotype | IgG1 |
| Format | Protein A/G purified, low endotoxin |
| Size | 50mg |
| Concentration | 5mg/ml |
| Applications | Functional Assays. RUO |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: detects human CD3/CD20. This non-therapeutic antibody uses the same sequence as the therapeutic antibody Mosunetuzumab. ichorbio's Mosunetuzumab biosimilar is a bispecific, humanized monoclonal antibody with potential antineoplastic activity. Anti-CD20/CD3 bispecific monoclonal antibody BTCT4465A contains two antigen-recognition sites: one for human CD3, a T-cell surface antigen, and one for human CD20, a tumor-associated antigen (TAA) that is exclusively expressed on B cells during most stages of B-cell development and is often overexpressed in B-cell malignancies. Upon administration, BTCT4465A binds to both T cells and CD20-expressing tumor B cells; this cross-links T cells to tumor cells, and may result in a potent cytotoxic T-lymphocyte (CTL) response against CD20-expressing tumor B cells. |
| Immunogen | n/a |
| Other Names | BTCT4465A |
| Gene, Accession # | UniProt: P07766, P11836 |
| Catalog # | ICH5026-50mg |
| Price | $6000 |
| Order / More Info | CD3e + CD20 (Mosunetuzumab biosimilar) Antibody from ICHORBIO |
| Product Specific References | n/a |
ICHORBIO
ICHORBIO
Boston House, Grove Business Park
Downsview Road
Wantage OX12 9FF ENGLAND
orders@ichor.bio
https://ichor.bio
U.S. OFFICE
987 Old Eagle School Rd, Ste 709
Wayne, PA 19087
us@ichor.bio
Profile of ICHORBIO